SMT201600135B - Nuovi inibitori della s-nitrosoglutatione riduttasi - Google Patents
Nuovi inibitori della s-nitrosoglutatione riduttasiInfo
- Publication number
- SMT201600135B SMT201600135B SM201600135T SM201600135T SMT201600135B SM T201600135 B SMT201600135 B SM T201600135B SM 201600135 T SM201600135 T SM 201600135T SM 201600135 T SM201600135 T SM 201600135T SM T201600135 B SMT201600135 B SM T201600135B
- Authority
- SM
- San Marino
- Prior art keywords
- riduttasi
- nitrosoglutation
- new inhibitors
- inhibitors
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30395210P | 2010-02-12 | 2010-02-12 | |
PCT/US2011/024353 WO2011100433A1 (en) | 2010-02-12 | 2011-02-10 | Novel s-nitrosoglutathione reductase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201600135B true SMT201600135B (it) | 2016-07-01 |
Family
ID=44368117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201600135T SMT201600135B (it) | 2010-02-12 | 2016-05-10 | Nuovi inibitori della s-nitrosoglutatione riduttasi |
Country Status (21)
Country | Link |
---|---|
US (3) | US8759548B2 (it) |
EP (1) | EP2533638B1 (it) |
JP (2) | JP5878484B2 (it) |
KR (1) | KR20120138746A (it) |
CN (1) | CN102869255B (it) |
AU (1) | AU2011215833B2 (it) |
BR (1) | BR112012019529A2 (it) |
CA (1) | CA2787633A1 (it) |
DK (1) | DK2533638T3 (it) |
ES (1) | ES2565345T3 (it) |
HK (1) | HK1178742A1 (it) |
HR (1) | HRP20160450T1 (it) |
HU (1) | HUE029012T2 (it) |
IL (1) | IL220956A (it) |
PL (1) | PL2533638T3 (it) |
RS (1) | RS54618B1 (it) |
RU (1) | RU2585763C2 (it) |
SI (1) | SI2533638T1 (it) |
SM (1) | SMT201600135B (it) |
WO (1) | WO2011100433A1 (it) |
ZA (1) | ZA201205374B (it) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102869255B (zh) * | 2010-02-12 | 2016-08-31 | 内瓦利斯治疗公司 | S-亚硝基谷胱甘肽还原酶的新抑制剂 |
US8481590B2 (en) | 2010-02-12 | 2013-07-09 | N30 Pharmaceuticals, Inc. | Chromone inhibitors of S-nitrosoglutathione reductase |
EP2977050A1 (en) * | 2010-10-08 | 2016-01-27 | Nivalis Therapeutics, Inc. | Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors |
WO2012083165A1 (en) | 2010-12-16 | 2012-06-21 | N30 Pharmaceuticals, Llc | Novel substituted bicyclic aromatic compounds as s-nitrosoglutathione reductase inhibitors |
US20140094465A1 (en) * | 2011-06-10 | 2014-04-03 | N30 Pharmaceuticals, Inc. | Compounds as S-Nitrosoglutathione Reductase Inhibitors |
RU2014121983A (ru) | 2011-10-31 | 2015-12-10 | Ксенон Фармасьютикалз Инк. | Биарильные простоэфирные сульфонамиды и их применение в качестве терапевтических средств |
ES2586213T3 (es) | 2011-10-31 | 2016-10-13 | Xenon Pharmaceuticals Inc. | Compuestos de bencenosulfonamida y su uso como agentes terapéuticos |
TW201400446A (zh) | 2012-05-22 | 2014-01-01 | Genentech Inc | N-取代之苯甲醯胺及其使用方法 |
CA2878478A1 (en) | 2012-07-06 | 2014-01-09 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
MX2015011436A (es) | 2013-03-14 | 2016-06-06 | Genentech Inc | Triazolopiridinas sustituidas y metodos para usarlas. |
WO2014144545A2 (en) | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Substituted benzoxazoles and methods of use thereof |
CN105793238B (zh) | 2013-11-27 | 2019-12-24 | 基因泰克公司 | 经取代的苯甲酰胺及其使用方法 |
CN106715418A (zh) | 2014-07-07 | 2017-05-24 | 基因泰克公司 | 治疗化合物及其使用方法 |
MX2017014715A (es) | 2015-05-22 | 2018-03-16 | Genentech Inc | Benzamidas sustituidas y metodos para utilizarlas. |
WO2017035271A1 (en) | 2015-08-27 | 2017-03-02 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
US10399946B2 (en) | 2015-09-10 | 2019-09-03 | Laurel Therapeutics Ltd. | Solid forms of an S-Nitrosoglutathione reductase inhibitor |
WO2017058821A1 (en) | 2015-09-28 | 2017-04-06 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
JP2018535234A (ja) | 2015-11-25 | 2018-11-29 | ジェネンテック, インコーポレイテッド | ナトリウムチャネル遮断薬として有用な置換ベンズアミド |
EP3436432B1 (en) | 2016-03-30 | 2021-01-27 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
MA46546A (fr) | 2016-10-17 | 2021-05-05 | Genentech Inc | Composés thérapeutiques et leurs procédés d'utilisation |
JP2020511511A (ja) | 2017-03-24 | 2020-04-16 | ジェネンテック, インコーポレイテッド | ナトリウムチャネル阻害剤としての4−ピペリジン−n−(ピリミジン−4−イル)クロマン−7−スルホンアミド誘導体 |
WO2018177993A1 (de) | 2017-03-31 | 2018-10-04 | Bayer Cropscience Aktiengesellschaft | Pyrazole zur bekämpfung von arthropoden |
JP2021514980A (ja) | 2018-02-26 | 2021-06-17 | ジェネンテック, インコーポレイテッド | 疼痛及び関連病態に対するピリジン−スルホンアミド化合物及びその使用 |
WO2019191702A1 (en) | 2018-03-30 | 2019-10-03 | F. Hoffmann-La Roche Ag | Substituted hydro-pyrido-azines as sodium channel inhibitors |
CN114667166A (zh) * | 2019-08-23 | 2022-06-24 | 诺塔实验室有限责任公司 | 一氧化氮生成*** |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8626344D0 (en) | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
WO1997032872A1 (en) | 1996-03-05 | 1997-09-12 | Imperial College Of Science Technology And Medicine | Compounds with a sulfamate group |
AU1975297A (en) | 1996-02-21 | 1997-09-10 | Glycomed Incorporated | Sialyl lewisx mimetics containing flavanoid backbones |
US6057367A (en) | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
US5919813C1 (en) | 1998-03-13 | 2002-01-29 | Univ Johns Hopkins Med | Use of a protein tyrosine kinase pathway inhibitor in the treatment of diabetic retinopathy |
KR20000001793A (ko) * | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 |
KR100295206B1 (ko) | 1998-08-22 | 2001-07-12 | 서경배 | 디아릴벤조피란유도체및이를함유하는시클로옥시게네이즈-2저해제조성물 |
US7572788B2 (en) | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
AU2001255696A1 (en) | 2000-04-27 | 2001-11-07 | Geron Corporation | Telomerase inhibitors and methods of their use |
US7049308B2 (en) | 2000-10-26 | 2006-05-23 | Duke University | C-nitroso compounds and use thereof |
US6359182B1 (en) | 2000-10-26 | 2002-03-19 | Duke University | C-nitroso compounds and use thereof |
US7179791B2 (en) | 2001-01-11 | 2007-02-20 | Duke University | Inhibiting GS-FDH to modulate NO bioactivity |
AUPR255401A0 (en) | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
US20030181510A1 (en) | 2002-03-19 | 2003-09-25 | Robert Baker | Inhibition of muscle regeneration following myectomy |
KR20060011785A (ko) | 2002-06-27 | 2006-02-03 | 디 인다우먼트 포 리써치 인 휴먼 바이올로지, 인크. | Aldh 억제에 유용한 화합물 |
US20050080024A1 (en) | 2002-08-15 | 2005-04-14 | Joseph Tucker | Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
EP1556031A4 (en) | 2002-10-22 | 2009-03-25 | Jenken Biosciences Inc | CHROMONES AND CHROMIUM DERIVATIVES, AND USES THEREOF |
US20050014697A1 (en) | 2003-06-04 | 2005-01-20 | Stamler Jonathan S. | Compositions and methods for modulating S-nitrosoglutathione reductase |
CN1241921C (zh) | 2003-07-09 | 2006-02-15 | 东华大学 | 含氟异黄酮衍生物、制造方法及其用途 |
US7253208B2 (en) | 2004-04-08 | 2007-08-07 | Aryx Therapeutics | Materials and methods for treating coagulation disorders |
ATE451361T1 (de) | 2004-04-08 | 2009-12-15 | Aryx Therapeutics | Materialien und methoden zur behandlung von koagulationsstörungen |
KR20070088798A (ko) * | 2004-12-21 | 2007-08-29 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 그의 5-ht 수용체 리간드로서의 용도 |
JP2008533039A (ja) * | 2005-03-11 | 2008-08-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 抗アポトーシスBcl−2ファミリーメンバーのクロメン−4−オン阻害剤およびその使用 |
WO2007016525A2 (en) | 2005-07-29 | 2007-02-08 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
EP2046769A2 (en) * | 2006-07-27 | 2009-04-15 | Cv Therapeutics, Inc. | Aldh-2 inhibitors in the treatment of addiction |
GB0618168D0 (en) | 2006-09-15 | 2006-10-25 | Babraham Inst | Compounds |
US20100152284A1 (en) | 2006-10-30 | 2010-06-17 | Novogen Research Pty Ltd | Prevention and reversal of chemotherapy-induced peripheral neuropathy |
WO2009026657A1 (en) | 2007-08-29 | 2009-03-05 | The University Of Sydney | Flavonoid ppar agonists |
WO2009076665A1 (en) * | 2007-12-13 | 2009-06-18 | Indiana University Research And Technology Corporation | Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase |
WO2010107476A1 (en) | 2009-03-19 | 2010-09-23 | Duke University | Inhibiting gsnor |
CN102869255B (zh) | 2010-02-12 | 2016-08-31 | 内瓦利斯治疗公司 | S-亚硝基谷胱甘肽还原酶的新抑制剂 |
US8481590B2 (en) * | 2010-02-12 | 2013-07-09 | N30 Pharmaceuticals, Inc. | Chromone inhibitors of S-nitrosoglutathione reductase |
US20140094465A1 (en) * | 2011-06-10 | 2014-04-03 | N30 Pharmaceuticals, Inc. | Compounds as S-Nitrosoglutathione Reductase Inhibitors |
-
2011
- 2011-02-10 CN CN201180008906.2A patent/CN102869255B/zh not_active Expired - Fee Related
- 2011-02-10 JP JP2012552997A patent/JP5878484B2/ja not_active Expired - Fee Related
- 2011-02-10 SI SI201130784A patent/SI2533638T1/sl unknown
- 2011-02-10 HU HUE11742796A patent/HUE029012T2/en unknown
- 2011-02-10 RS RS20160165A patent/RS54618B1/en unknown
- 2011-02-10 RU RU2012132692/04A patent/RU2585763C2/ru not_active IP Right Cessation
- 2011-02-10 AU AU2011215833A patent/AU2011215833B2/en not_active Ceased
- 2011-02-10 CA CA2787633A patent/CA2787633A1/en not_active Abandoned
- 2011-02-10 EP EP11742796.3A patent/EP2533638B1/en active Active
- 2011-02-10 KR KR1020127020738A patent/KR20120138746A/ko not_active Application Discontinuation
- 2011-02-10 PL PL11742796T patent/PL2533638T3/pl unknown
- 2011-02-10 DK DK11742796.3T patent/DK2533638T3/en active
- 2011-02-10 BR BR112012019529A patent/BR112012019529A2/pt not_active IP Right Cessation
- 2011-02-10 US US13/521,833 patent/US8759548B2/en not_active Expired - Fee Related
- 2011-02-10 ES ES11742796.3T patent/ES2565345T3/es active Active
- 2011-02-10 WO PCT/US2011/024353 patent/WO2011100433A1/en active Application Filing
-
2012
- 2012-07-15 IL IL220956A patent/IL220956A/en not_active IP Right Cessation
- 2012-07-18 ZA ZA2012/05374A patent/ZA201205374B/en unknown
-
2013
- 2013-05-14 HK HK13105760.2A patent/HK1178742A1/zh not_active IP Right Cessation
-
2014
- 2014-05-30 US US14/291,709 patent/US9187447B2/en not_active Expired - Fee Related
-
2015
- 2015-09-29 JP JP2015190968A patent/JP2016040285A/ja active Pending
- 2015-10-27 US US14/924,650 patent/US9707212B2/en not_active Expired - Fee Related
-
2016
- 2016-04-27 HR HRP20160450TT patent/HRP20160450T1/hr unknown
- 2016-05-10 SM SM201600135T patent/SMT201600135B/it unknown
Also Published As
Publication number | Publication date |
---|---|
IL220956A (en) | 2015-09-24 |
US8759548B2 (en) | 2014-06-24 |
AU2011215833B2 (en) | 2015-07-09 |
HK1178742A1 (zh) | 2013-09-19 |
BR112012019529A2 (pt) | 2019-09-24 |
EP2533638A1 (en) | 2012-12-19 |
WO2011100433A1 (en) | 2011-08-18 |
US20140275185A1 (en) | 2014-09-18 |
JP2016040285A (ja) | 2016-03-24 |
RS54618B1 (en) | 2016-08-31 |
JP5878484B2 (ja) | 2016-03-08 |
US20120289555A1 (en) | 2012-11-15 |
HRP20160450T1 (hr) | 2016-05-20 |
US9707212B2 (en) | 2017-07-18 |
SI2533638T1 (sl) | 2016-05-31 |
CN102869255A (zh) | 2013-01-09 |
JP2013519680A (ja) | 2013-05-30 |
EP2533638A4 (en) | 2013-06-05 |
PL2533638T3 (pl) | 2016-08-31 |
EP2533638B1 (en) | 2016-02-10 |
ES2565345T3 (es) | 2016-04-04 |
CA2787633A1 (en) | 2011-08-18 |
RU2585763C2 (ru) | 2016-06-10 |
KR20120138746A (ko) | 2012-12-26 |
US20160045478A1 (en) | 2016-02-18 |
CN102869255B (zh) | 2016-08-31 |
DK2533638T3 (en) | 2016-04-25 |
AU2011215833A1 (en) | 2012-08-30 |
US9187447B2 (en) | 2015-11-17 |
RU2012132692A (ru) | 2014-02-10 |
HUE029012T2 (en) | 2017-02-28 |
ZA201205374B (en) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600135B (it) | Nuovi inibitori della s-nitrosoglutatione riduttasi | |
SMT201500271B (it) | Inibitori di neprilisina | |
DK3178818T3 (da) | Pyrazolylquinoxalinkinasehæmmere | |
SMT201500291B (it) | Nuovi agenti antimalarici | |
DK2371923T3 (da) | Aflejringshæmmer | |
BR112012028556A2 (pt) | Indóis | |
DE102011100241A8 (de) | Nitridhalbleiterbauteil | |
DE112011100715T8 (de) | Hardware-hilfs-thread | |
CR20130111A (es) | Triazina-oxidiazoles | |
DE10170954T8 (de) | Mikrowellendruckgarer | |
SMT201500264B (it) | Mutanti della frataxina | |
DE102011002623A8 (de) | Ventilsteuerzeitversteller | |
BR112012019494A2 (pt) | dispositivo elétrico | |
DE102010019119B8 (de) | Cuttermesser | |
BR112013014148A2 (pt) | inibidores de corrosão | |
DE102010038420A8 (de) | Reinigungungsvorrichtung | |
CO6801789A2 (es) | N-hetarilmetil pirazolilcarboxamidas | |
DE102010035554B8 (de) | Fußtüröffner | |
DK2402077T3 (da) | Isolatorenhed | |
DK2571902T3 (da) | Ny fremgangsmåde | |
IT1402715B1 (it) | Sonda di tastaggio | |
BR112013005966A2 (pt) | refrigerador | |
DK2593734T3 (da) | Rimfrit køleskab | |
FR2965072B3 (fr) | Horloge | |
FR2955136B1 (fr) | Arret de vantail |